Ricevi le ultime notizie sulle azioni Femasys con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di FEMY

Ultime notizie per

FEMASYS INC

Femasys

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Femasys Inc

Press Releases

General

Femasys Secures UK Regulatory Approval of FemBloc Permanent Birth Control

Health Care

Femasys Announces FemSperm™ Kit to Activate Gynecologists and Advance FemaSeed® Fertility Platform

News

Financing

Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios

Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand

Femasys Expands FemSperm™ Product Line with New Insemination Prep Kit to Broaden Gynecology-Based Access to FemaSeed®

Femasys Partners with Medical Electronic Systems to Launch FemSperm™ Analysis Kit for use with FemaSeed

Penny Stocks

Femasys Accelerates European Growth for FemBloc® with Kebomed Partnership

Femasys to Exhibit at the ASRM 2025 Scientific Congress & Expo

Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe

FEMY

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares

Inspira Technologies Oxy

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

Lifeward

Milestone Scientific

Modular Medical

Myomo

Neuraxis

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Nexalin Technology

PAVmed

Profusa

Predictive Oncology

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

SINTX Technologies

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tenon Medical

Trinity Biotech plc - American Depositary Shares

Comments

Femasys Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO